Objectives: We aimed to investigate the effect of the Prognostic Nutritional Index (PNI) and other well?known prognostic factors in gastric cancer (GC) patients based on pathological parameters and to analyze its predictive value for gastric cancer survival. Methods: The PNI was calculated by using serum albumin and total lymphocyte count on the time diagnosis. Associations between PNI and clinical, demografic and histopathological parameters were analyzed. Results: Data of 364 patients with GC were evaluated retrospectively. The median OS was 27 months (95%CI, 20.3 to 33.6)) in the high prognostic nutrition index and 14 months (95%CI, 11.5 to 16.4) in the low prognostic nutrition index (p<0.0001). In the multivariate Cox regression model, prognostic nutrition index (B=0.410, 95% CI=1.023 to 2.221 p=0.038), lymphovascular invasion (B=.907, 95% CI=1.398 to 4.390 p=0.002), stage (B=0.842 95% CI=1.349 to 3.992 p=0.002) and lymph node metastasis (B=-.896, 95% CI=1.199 to 4.908 p=0.014) were statistically significant predictors for OS. Conclusion: The PNI, a simple, well-validated, and cost-effective biomarker is an independent prognostic factor for OS in patients with GC. Our results can emphasize prognostic benefit from careful nutritional support during diagnosis and treatment for patients with poor nutritional parameters. Keywords: Prognostic nutrition index, gastric cancer, survival
Corresponding Author: Yasar Yildiz